ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

MTNB Matinas Biopharma Holdings Inc

0,1756
-0,0011 (-0,62%)
11 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Matinas Biopharma Holdings Inc MTNB AMEX Common Stock
  Änderung Änderung % Aktuell Zeit
-0,0011 -0,62% 0,1756 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
0,1767 0,1673 0,177 0,1756 0,1767
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
09.5.202422:06EDGAR2Form 8-K - Current report
09.5.202422:05GLOBEMatinas BioPharma Reports First Quarter 2024 Financial..
09.5.202422:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07.5.202414:00GLOBEMatinas BioPharma’s LNC Platform for the Delivery of Small..
02.5.202413:00GLOBEMatinas BioPharma to Webcast Conference Call to Discuss..
30.4.202414:00GLOBEIn Vivo Efficacy of Matinas BioPharma’s Oral MAT2203 in..
03.4.202414:30GLOBEMatinas BioPharma Prices $10 Million Registered Direct..
27.3.202421:05GLOBEMatinas BioPharma Reports 2023 Financial Results and..
25.3.202413:00GLOBEMatinas BioPharma Announces Positive in vivo Safety Data..
22.3.202414:15GLOBEThree Patients with Invasive Fusarium Infection in Matinas..
22.3.202411:30GLOBEMatinas BioPharma Regains Compliance with NYSE American..
26.2.202414:05EDGAR2Form 8-K - Current report
26.2.202414:00GLOBEMatinas BioPharma Provides Positive Outcomes Update on the..
20.2.202413:35EDGAR2Form 8-K - Current report
20.2.202413:30GLOBEMatinas BioPharma Successfully Reaches Agreement with FDA..
09.1.202413:30EDGAR2Form 8-K - Current report
03.1.202413:00GLOBEMatinas BioPharma to Present at Biotech Showcase 2024
27.12.202313:40EDGAR2Form 8-K - Current report
27.12.202313:30GLOBEMatinas BioPharma Demonstrates in vivo Biological Activity..
21.12.202313:40EDGAR2Form 8-K - Current report
21.12.202313:30GLOBEMatinas BioPharma Provides Update to MAT2203 Regulatory and..
16.12.202303:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.12.202303:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.12.202303:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.12.202303:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.12.202303:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.12.202303:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.11.202313:30EDGAR2Form 8-K - Current report
09.11.202323:25EDGAR2Form 8-K - Current report
08.11.202322:06EDGAR2Form 8-K - Current report
08.11.202322:05GLOBEMatinas BioPharma Reports Third Quarter 2023 Financial..
08.11.202322:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07.11.202313:30GLOBEMatinas BioPharma Announces Positive in vivo Efficacy..
03.11.202321:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.11.202322:20EDGAR2Form 8-K - Current report
01.11.202312:00GLOBEMatinas BioPharma to Webcast Conference Call to Discuss..
11.10.202316:25APSBiotech Catches Massive Premarket Bid
11.10.202313:30GLOBEPatient with Candida krusei Infection in Matinas BioPharma’s..
28.9.202313:00GLOBEMatinas BioPharma to Present at Two Investment Conferences..
27.9.202313:00GLOBEMatinas BioPharma to Feature MAT2203 in a Pipeline..
22.9.202323:25EDGAR2Form 8-K - Current report
22.9.202323:25GLOBEMatinas BioPharma Announces Notification of NYSE American..
21.9.202315:35GLOBEDawson James Securities Announces October Date for 8th..
20.9.202313:30EDGAR2Form 8-K - Current report
19.9.202323:25EDGAR2Form DEF 14A - Other definitive proxy statements
08.9.202323:15EDGAR2Form PRE 14A - Other preliminary proxy statements
06.9.202313:00GLOBEMatinas BioPharma to Participate in the H.C. Wainwright..
22.8.202313:30GLOBEMatinas BioPharma Announces Publication of Results from the..
09.8.202322:06EDGAR2Form 8-K - Current report
09.8.202322:05GLOBEMatinas BioPharma Reports Second Quarter 2023 Financial..